×
ADVERTISEMENT

MAY 15, 2017

Companies Collaborate To Reduce Postsurgical Opioid Dependence

A new initiative to identify preoperative patients who may be predisposed to developing dependence on opioid analgesics could facilitate treatment plans that reduce their exposure to opioids and mitigate that risk.

The joint endeavor by specialty pharmaceutical manufacturer Pacira Pharmaceuticals and therapeutic management firm GeneAlign has incorporated behavioral histories and pharmacogenetic and pharmacogenomic testing into the preoperative risk assessments for selected procedures at pilot